ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
One Experience

One Experience (ALEXP)

0.496
0.194
(64.24%)
Closed February 08 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.496
Bid
0.32
Ask
0.68
Volume
2,537
0.32 Day's Range 0.496
0.30 52 Week Range 0.69
Market Cap
Previous Close
0.302
Open
0.32
Last Trade
1
@
0.496
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
3,500
Shares Outstanding
9,162,167
Dividend Yield
-
PE Ratio
-6.52
Earnings Per Share (EPS)
-0.08
Revenue
5.18M
Net Profit
-703k

About One Experience

Sector
Management Consulting Svcs
Industry
Management Consulting Svcs
Headquarters
Boulogne-billancourt, Hauts-de-seine, Fra
Founded
-
One Experience is listed in the Management Consulting Svcs sector of the Euronext with ticker ALEXP. The last closing price for One Experience was 0.30 €. Over the last year, One Experience shares have traded in a share price range of 0.30 € to 0.69 €.

One Experience currently has 9,162,167 shares outstanding. The market capitalization of One Experience is 2.77 € million. One Experience has a price to earnings ratio (PE ratio) of -6.52.

ALEXP Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.1128.49740932640.3860.4960.330480.30530503DE
40.096240.40.60.382990.48729847DE
120.15645.88235294120.340.60.335000.46415754DE
260.12433.33333333330.3720.690.320290.48743103DE
52-0.02-3.875968992250.5160.690.314590.48559119DE
156-0.166-25.07552870090.6621.1850.318080.58063148DE
260-0.166-25.07552870090.6621.1850.318080.58063148DE

ALEXP - Frequently Asked Questions (FAQ)

What is the current One Experience share price?
The current share price of One Experience is 0.496 €
How many One Experience shares are in issue?
One Experience has 9,162,167 shares in issue
What is the market cap of One Experience?
The market capitalisation of One Experience is EUR 2.77M
What is the 1 year trading range for One Experience share price?
One Experience has traded in the range of 0.30 € to 0.69 € during the past year
What is the PE ratio of One Experience?
The price to earnings ratio of One Experience is -6.52
What is the cash to sales ratio of One Experience?
The cash to sales ratio of One Experience is 0.89
What is the reporting currency for One Experience?
One Experience reports financial results in EUR
What is the latest annual turnover for One Experience?
The latest annual turnover of One Experience is EUR 5.18M
What is the latest annual profit for One Experience?
The latest annual profit of One Experience is EUR -703k
What is the registered address of One Experience?
The registered address for One Experience is 8 RUE BARTHELEMY DANJOU, BOULOGNE-BILLANCOURT, HAUTS-DE-SEINE, 92100
What is the One Experience website address?
The website address for One Experience is groupe.one-experience.fr
Which industry sector does One Experience operate in?
One Experience operates in the MANAGEMENT CONSULTING SVCS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCABCabasse SA
0.77 €
(67.39%)
27.75k
ALEXPOne Experience
0.496 €
(64.24%)
2.54k
VTRVitura
5.80 €
(62.92%)
2.37k
DMSBSDiagnostic Medical Systems
0.007 €
(40.00%)
15.1k
ALVERVergnet
0.0009 €
(28.57%)
23.09M
ALCYBCybergun
0.0001 €
(-50.00%)
41.24k
BAIOdyssey Acquisition SA
0.1285 €
(-49.80%)
834.05k
ALALOAcheterLouerFR
0.0148 €
(-34.80%)
675.2k
MLWEYWeya
0.018 €
(-33.33%)
52.31k
MLCOTCoretech 5
0.0335 €
(-33.00%)
61k
ATOAtos SE
0.0021 €
(0.00%)
1.12B
ALVERVergnet
0.0009 €
(28.57%)
23.09M
ALCYBCybergun
0.0001 €
(-50.00%)
18.59M
ALHGLouis Hachette Group
1.331 €
(-2.90%)
11.49M
BCPBanco Comercial Portugues SA
0.5008 €
(-1.14%)
10.67M

Discussion

View Full Feed
thecrusher2011 thecrusher2011 3 minutes ago
https://youtu.be/8LWV2cveyT4?feature=shared

This is a good video for you. It's almost a play-by-play documentary of somebody who got deprogrammed.
BurgerKing82 BurgerKing82 3 minutes ago
....
YCRM
Batman412 Batman412 4 minutes ago
I might as well pick up 10million here please sell to me when I bid 
TONR
sentiment_stocks sentiment_stocks 4 minutes ago
I’d prefer not to rot in hell, at least not for eternity. :)
NWBO
Number sleven Number sleven 4 minutes ago
Kiwi, I'm not going to debate this with you. We have no information about the nature of the Chinese clinical trial.
Sleven,
AMRN
thundersteel thundersteel 6 minutes ago
Interesting and well thought out analysis, deduction, speculation….hope your right

That type of merger could catapult this to .08-10 on news…let’s hope your dots are
connected correctly….ty

TS
LICH
SC8 SC8 7 minutes ago
Just think how far we might be now if MK didn't spend most of his time peddling hopeless IsoPet and had Dr Fisher not so Fubared the rabbit studies that JHU had to repeat with proper monitoring. Likewise how far we'd be if MK had just delivered what FDA told him rather than wasting years arguing ag
RDGL
nwtf nwtf 7 minutes ago
I cant believe you are this stupid. You actually think people here want to buy shares of this POS and be stuck like you ?????
ERHE
xodcode xodcode 8 minutes ago
Wednesday is just another day in the Anavex journey.

What any Anavex investor needs to determine is the probability of EMA approval. All else, for the time being, is small potatoes.

If Anavex is EMA approved, one can anticipate a HUGE jump in market cap, perhaps by mul
AVXL
delerious1 delerious1 9 minutes ago
....and the other beauty of all this, besides the fun of holding shares is that, that is where I get my reward....not only am I going to make some big bucks , and enjoy the huge volume days ahead....but I will be rewarded from my ownership of actual shares....that is how I'm paid... I buy shares and
NBRI
crazy horse 0 crazy horse 0 9 minutes ago
USAID—doesn’t even stand for U.S. “AID” it stands for “United States Agency for International Development” and their budget is BIGGER than the State Dept. and the actual CIA COMBINED. More tax payer dollars spent.

https://www.facebook.com/todd.robert.abbott/videos/618954960962378?ido
jour_trader jour_trader 9 minutes ago
If SC doesn't accept, we should be nearing final steps mid-year from legal standpoint. Still awaiting on FDA approval as well. 
ELTP
Lime Time Lime Time 10 minutes ago
Well the price of gas will make everything else come down. Snow started here now. Couple inches, but cold
Whalatane Whalatane 11 minutes ago
Its from date of approval in China July 24 .
Here's Perplexities idea

To design the smallest and shortest trial to confirm the REDUCE-IT findings in a Chinese population, the following elements would be essential:
Key Design Features
Population
Sample Size
AMRN
WALLnut WALLnut 11 minutes ago
Your desperate spin is getting embarrassing. You throw around words like ‘failure’ and ‘incompetence’ while completely ignoring how early-stage trials actually work. So let’s break down your nonsense piece by piece:

1️⃣ ‘Patient is fine? Give me a f-ing break!’
? The entire poi
RDGL
BurgerKing82 BurgerKing82 12 minutes ago
Bottomed?
BANT
MasterBlastr MasterBlastr 12 minutes ago
I wanna go to Mars , , ,
rjs1 rjs1 12 minutes ago
GBT Technologies Adapts Pioneering Apollo Technology for Next-Generation Counter-Drone System
SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) –


GBT Technologies Inc. (OTC PINK: GTCH) (the “Company”) has recently announced the use in a testing scenario of its innovative Apol
GTCH
dukeb dukeb 12 minutes ago
Yes, the tie in to Trump isn't there.

I think the point of the post was to suss out the libs...as to what they believe vs. what they don't believe.

Perhap the point was that there aren't any anti-black or anti-gay bias incidents but the posted is clearly an idiot so the
tansilver tansilver 13 minutes ago
It's not you. There's nothing really to "get". The statement that the new S-1 implies a buyout coming is as far from the truth as it gets. At best, the poster is misinformed, at worst, it's purposely misleading.

The S-1 indicates the exact opposite. It means Mr. Thompson intends t
KBLB
Lykiri Lykiri 13 minutes ago
I believe many people have been following the story of Professor Richard Scolyer. Unfortunately, today he shared difficult news—his latest MRI scan showed signs of recurrence.

Professor Scolyer, a world-renowned pathologist and melanoma expert, was diagnosed in June 2023 with Grade 4
NWBO

Your Recent History

Delayed Upgrade Clock